Valuation: Medicure Inc.

Market Cap 11.06M 7.81M 6.87M 6.36M 5.86M 747M 11.3M 75.91M 29.69M 368M 29.35M 28.71M 1.27B P/E 2024
-8.8x
P/E 2025 -1.68x
Enterprise Value 8.12M 5.73M 5.04M 4.66M 4.3M 548M 8.3M 55.71M 21.79M 270M 21.54M 21.07M 931M EV / Sales 2024
0.13x
EV / Sales 2025 0.31x
Free-Float
72.7%
Yield 2024 *
-
Yield 2025 -
1 day-1.89%
1 week-19.38%
Current month-19.38%
3 months-14.75%
6 months-10.34%
Current year-8.77%
1 week 1.04
Extreme 1.04
1.06
1 month 1
Extreme 1
1.29
Current year 0.85
Extreme 0.85
1.35
1 year 0.85
Extreme 0.85
1.43
3 years 0.63
Extreme 0.63
1.8
5 years 0.63
Extreme 0.63
1.8
10 years 0
Extreme 0
10.67
Manager TitleAgeSince
Chief Executive Officer 79 14/09/1997
Director of Finance/CFO - 31/05/2022
Chief Tech/Sci/R&D Officer - 30/06/2019
Director TitleAgeSince
Chairman 79 14/09/1997
Director/Board Member 92 27/02/2000
Director/Board Member 56 21/01/2013
Date Insider Type Main position Quantity % Market Cap.
06-21Buy

Chief Executive Officer

1,000 0.0096%
06-21Buy

Chief Executive Officer

200 0.0019%
06-21Buy

Chief Executive Officer

2,500 0.0240%
Change 5-day change 1-year change 3-year change Capi.($)
-1.89%-19.38%-14.05%-7.96% 7.82M
-2.48%-3.13%+55.85%+89.65% 54.88B
-0.55%-8.57%+58.09%+124.47% 54.63B
-5.60%-2.20%+11.16%+437.37% 25.06B
-1.55%-7.66%-20.21%-17.37% 23.14B
-1.69%-0.64%+40.04%-0.48% 19.87B
+1.87%+1.87%+38.13%-26.14% 17.55B
-2.72%-0.60%+187.08%+351.91% 16.5B
-2.42%+1.00%+48.24%+635.77% 15.75B
-0.81%+0.34%+24.92%+189.31% 14.2B
Average -1.78%-2.52%+42.92%+177.65% 24.16B
Weighted average by Cap. -1.81%-1.56%+48.50%+166.89%

Financials

2024 2025
Net sales 21.91M 15.47M 13.6M 12.59M 11.6M 1.48B 22.38M 150M 58.79M 728M 58.12M 56.85M 2.51B 28.86M 20.37M 17.91M 16.58M 15.28M 1.95B 29.48M 198M 77.44M 959M 76.55M 74.88M 3.31B
Net income -1.04M -734K -645K -597K -550K -70.19M -1.06M -7.13M -2.79M -34.53M -2.76M -2.7M -119M -7.1M -5.01M -4.41M -4.08M -3.76M -479M -7.25M -48.7M -19.05M -236M -18.83M -18.42M -814M
Net Debt -6.32M -4.46M -3.92M -3.63M -3.34M -427M -6.45M -43.34M -16.95M -210M -16.76M -16.39M -725M -2.94M -2.08M -1.83M -1.69M -1.56M -199M -3.01M -20.2M -7.9M -97.83M -7.81M -7.64M -338M
Logo Medicure Inc.
Medicure Inc. is a pharmaceutical company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. Its primary focus is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through its United States subsidiary, Medicure Pharma Inc. It operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medications for all Americans, together with customer service and free home delivery. It operates Gateway Medical Pharmacy, located in Portland, Oregon in a medical office building near transportation lines and multiple healthcare clinics and centers. It develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, and compositions containing P5P Analogues.
Employees
38
Date Price Change Volume
13/07/26 CA$1.040 -1.89% 1,000